Watch Ticker

Incannex Healthcare Limited American Depositary Shares

Go to Incannex Healthcare Limited American Depositary Shares Website

$0.40

-0.05 (-10.82%)

Live

Previous Close

$0.4447

Day Range

$0.395 - $0.4282

Previous Day Range

$0.4111 - $0.46

Market Cap

$36.1 million USD

Day Vol.

57.3 million

Previous Day Vol.

149.2 million

Currency

USD

Primary Exchange

Nasdaq

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Professor Ari Zoldan - 4 Psychedelic Stocks to Consider as Clinical Trials Heat up

Several biotechnology firms have psychedelic treatments in development, with promising results from clinical trials. The psychedelic market is expected to grow significantly, and most investors are favorable towards psychedelic stocks.

Related tickers: ATAI, CMPS, IXHL, MNMD.

Read Full Article

Incannex Healthcare - Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

NEW YORK and MELBOURNE, Australia, May 30, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies is pleased to announce that patient dosing has commenced in the Company’s Phase 2/3 clinical trial to assess safety and efficacy of IHL-42X in patients with obstructive sleep apnea (‘OSA’).

Related tickers: IXHL.

Read Full Article

Trending Tickers

Please sign in to view